From genotype to phenotype: a longitudinal study of a patient with hypertrophic cardiomyopathy due to a mutation in the MYBPC3 gene

[1]  V. Tsang,et al.  Myosin binding protein C phosphorylation in normal, hypertrophic and failing human heart muscle. , 2008, Journal of molecular and cellular cardiology.

[2]  M. Yacoub,et al.  The familial hypertrophic cardiomyopathy‐associated myosin mutation R403Q accelerates tension generation and relaxation of human cardiac myofibrils , 2008, The Journal of physiology.

[3]  H. Watkins,et al.  The molecular phenotype of human cardiac myosin associated with hypertrophic obstructive cardiomyopathy , 2008, Cardiovascular research.

[4]  H. Watkins,et al.  Evidence for haploinsufficiency as the mechanism of action of MyBP-C mutations that cause HCM , 2008 .

[5]  S. Harding,et al.  Cellular dysfunction and altered contractile protein post-translational modification in hypertrophic cardiomyopathy septal tissue , 2008 .

[6]  P. J. Griffiths,et al.  Dilated and Hypertrophic Cardiomyopathy Mutations in Troponin and &agr;-Tropomyosin Have Opposing Effects on the Calcium Affinity of Cardiac Thin Filaments , 2007, Circulation research.

[7]  V. Tsang,et al.  Altered function and post-translational modification of contractile proteins in myectomy samples from HOCM patients , 2007 .

[8]  P. Elliott,et al.  Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy. , 2006, European heart journal.

[9]  V. Tsang,et al.  Evidence for reduced troponin I phosphorylation and altered troponin function in patients with hypertrophic obstructive cardiomyopathy , 2006 .

[10]  N. Peters,et al.  Electromechanical properties of isolated myocardium from patients with hypertrophic obstructive cardiomyopathy (HOCM) , 2005 .

[11]  J. Tardiff.  Sarcomeric Proteins and Familial Hypertrophic Cardiomyopathy: Linking Mutations in Structural Proteins to Complex Cardiovascular Phenotypes , 2005, Heart failure reviews.

[12]  M. Antognozzi,et al.  Hypertrophic cardiomyopathy-related beta-myosin mutations cause highly variable calcium sensitivity with functional imbalances among individual muscle cells. , 2005, American journal of physiology. Heart and circulatory physiology.

[13]  A. Tajik,et al.  Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. , 2004, Journal of the American College of Cardiology.

[14]  A. Tajik,et al.  Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy. , 2004, Journal of the American College of Cardiology.

[15]  I. Kulikovskaya,et al.  Effect of extraction of myosin binding protein C on contractility of rat heart. , 2003, American journal of physiology. Heart and circulatory physiology.

[16]  M. Komajda,et al.  Hypertrophic Cardiomyopathy: Distribution of Disease Genes, Spectrum of Mutations, and Implications for a Molecular Diagnosis Strategy , 2003, Circulation.

[17]  H. Watkins,et al.  Alterations in Thin Filament Regulation Induced by a Human Cardiac Troponin T Mutant That Causes Dilated Cardiomyopathy Are Distinct from Those Induced by Troponin T Mutants That Cause Hypertrophic Cardiomyopathy* , 2002, The Journal of Biological Chemistry.

[18]  M. S. Hamid,et al.  Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical, haemodynamic and exercise outcomes. , 2002, European heart journal.

[19]  B. Brenner,et al.  Mutation of the myosin converter domain alters cross-bridge elasticity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[20]  D. Szczesna,et al.  Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy. , 2001, The Journal of biological chemistry.

[21]  H. Watkins,et al.  Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy. , 1999, Cardiovascular Research.

[22]  P. Tombe.  Altered contractile function in heart failure , 1998 .

[23]  C H Davies,et al.  Reduced contraction and altered frequency response of isolated ventricular myocytes from patients with heart failure. , 1995, Circulation.

[24]  H. C. Hartzell,et al.  Alterations in Ca2+ sensitive tension due to partial extraction of C- protein from rat skinned cardiac myocytes and rabbit skeletal muscle fibers , 1991, The Journal of general physiology.

[25]  W. Henry,et al.  Operative Treatment in Hypertrophic Subaortic Stenosis: Techniques, and the Results of Pre and Postoperative Assessments in 83 Patients , 1975, Circulation.

[26]  with familial , 2014 .

[27]  W. Paulus,et al.  Sarcomeric dysfunction in heart failure. , 2008, Cardiovascular research.

[28]  Steven B Marston,et al.  Troponin phosphorylation and regulatory function in human heart muscle: dephosphorylation of Ser23/24 on troponin I could account for the contractile defect in end-stage heart failure. , 2007, Journal of molecular and cellular cardiology.

[29]  P. D. de Tombe.  Myosin binding protein C in the heart. , 2006, Circulation research.

[30]  Matthew J. Tyska,et al.  R403Q and L908V mutant β-cardiac myosin from patients with familial hypertrophic cardiomyopathy exhibit enhanced mechanical performance at the single molecule level , 2004, Journal of Muscle Research & Cell Motility.

[31]  Z. Papp,et al.  Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins. , 2003, Cardiovascular research.

[32]  H. C. Hartzell,et al.  Alterations in C a 2 + Sensitive Tension Due to Partial Extraction of C-Protein from Rat Skinned Cardiac Myocytes and Rabbit Skeletal Muscle Fibers , 1991 .